- Visibility 444 Views
- Downloads 363 Downloads
- Permissions
- DOI 10.18231/j.ijmpo.2025.009
-
CrossMark
- Citation
Etiology of hepatocellular carcinoma- Indian scenario - A changing landscape
- Author Details:
-
Aprajita Mall *
-
Tejinder Kataria
Background: Recent studies from both India and abroad have shown a change in the etiological profile of hepatocellular carcinoma (HCC).
Aims: We aim to analyze the etiological spectrum and changing trends of HCC etiology in India at our tertiary centre.
Materials and Methods: The records of all patients diagnosed with HCC between May 2012 and November 2024 were extracted from the hospital-based electronic database. Medical records were reviewed for 430 patients who received treatment for HCC. Patient characteristics and demographics were recorded. Data was captured and analysed for the patients who recieved radiation therapy.
Results: Total number of patients analysed were 429 who were diagnosed as HCC. There was a male preponderance of 90.6%. HBV/HCV cases initially increased from 22.2% (2012-2015) to 42.2% (2016-2019) but later dropped to 35.6% (2020-2024). In contrast, NASH/Alcohol cases steadily increased from 13.8% (2012-2015) to 24.5% (2016-2019) and then sharply rose to 61.6% (2020-2024), making it the leading cause in recent years. The Chi-square value (27.517) and p-value (<0>
Conclusions: Rising HCC incidence rate is a cause for concern in India with viral hepatitis being the main cause. However, the increased incidence of non-viral HCC, particularly NASH-related, has been involved in the changing etiologies of HCC. Globally Nonalcoholic fatty liver disease (NAFLD) is swiftly becoming the most important cause of HCC. Effective strategies are needed to improve surveillance and early diagnosis in patients with high risk of developing hepatocellular cancer. NAFLD preventive strategies are an urgent need for public health in India.
Keywords: HCC, SBRT, PVTT, Nash, hepatitis B virus, hepatitis C virus
References
- Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pineros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021:10.1002/ijc.33588
[Google Scholar] - Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. GlobalCancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49
- Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000;5(3):224–37.
- Kulkarni AV, Fatima S, Sharma M, Kumar P, Gupta R, Padaki NR, et al. Lenvatinib for unresectable hepatocellular carcinoma: the first Indian experience. Gastro Hep. 2021;3(6):407–8.
- Giri S, Singh A. Epidemiology of Hepatocellular Carcinoma in India - An Updated Review for 2024. J Clin Exp Hepatol. 2024;14(6):101447.
- National Comprehensive Cancer Network. Hepatobiliary cancer (version 4.2024) Plymouth Meeting, PA: National Comprehensive Cancer Network; c2024 [cited 2024 Mar 1]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/hcc.pdf
- Schaub SK, Hartvigson PE, Lock MI, Høyer M, Brunner TB, Cardenes HR, et al. Stereotactic body radiation therapy for hepatocellular carcinoma: current trends and controversies. Technol Cancer Res Treat. 2018;17:1533033818790217.
- Dawson LA, Zhu A, Knox J, Zhu AX, Krishnan S, Guha C, et al. Stereotactic Body Radiotherapy vs Sorafenib Alone in et al / IP International Journal of Medical Paediatrics and Oncology 2025;11(2):40-45 45 45 Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2025;11(2):136–44.
- WHO: Hepatitis B. World Hepatitis Day 2016, 2016. https://cdn.who.int/media/docs/default-source/searo/india/health- topic-pdf/factsheet-b-hepatitisday2016.pdf?sfvrsn=da61ef0_2
- Kar P. Risk factors for hepatocellular carcinoma in India. J Clin Exp Hepatol. 2014;4(3):S34–S42.
- Chavda HJ. Hepatocellular carcinoma in India. Indian J Surg. 83:959-966, 2021
- Sarin SK, Kumar M, Eslam M, George J, Mahtab MA, Akbar SMF, et al. Liver diseases in the Asia-Pacific region: A Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020;5(2):167–228.
- Goel A, Seguy N, Aggarwal R. Burden of hepatitis C virus infection in India: A systematic review and meta-analysis. J Gastroenterol Hepatol 2019;34(2):321–9.
- Rajasekaran M, Sivagnanam G, Thirumalaikolundusubramainan P, Namasivayam K, Ravindranath C. Injection practices in Southern part of India. Public Health. 2003;117(3):208–13.
- Arvinder SS, Bhangui P, Kataria T, Baijal SS, Piplani T, Gautam D, et al. Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging. Transplantation. 2020;104(11):2334–45.
- Tohra S, Duseja A, Taneja S, et al: Experience with changing etiology and nontransplant curative treatment modalities for hepatocellular carcinoma in a real-life setting—A retrospective descriptive analysis. J Clin Exp Hepatol. 2021;11(6):682–90.
- Prabhakar T, Kaushal K, Prasad M, Gupta E, Sood A, Jain AK, et al. Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: A multi-centric study. Hepatol Int. 2023;17(9615).
- Bhadoria AS, Pathak V, Lahariya C. Non-alcoholic fatty liver disease (NAFLD) in India: Challenges and the ways forward. J Indian Med Assoc. 2022;120(4):52–5.
- Musunuri B, Shetty S, Bhat G, Udupa K, Pai A. Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India. Indian J Gastroenterol. 2022;41(2):127–34.
- Sarin SK, Kumar M, Eslam M, George J, Mahtab MA, Fazle Akbar SM, et al: Liver diseases in the Asia-Pacific region: A Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020;5(2):167–228.
- Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al: Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–50.
- Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol . 2019;16(10):589–604.
- Hung YW, Lee IC, Chi CT, Lee RC, Liu CA, Chiu NC, et al. Redefining tumor burden in patients with intermediate-stage hepato- cellular carcinoma: the seveneleven cri- teria. Liver Cancer. 2021;10(6):629–40.
- Matsuo Y. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview. Curr Oncol. 2023;30(2):2493–500.
- Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, et al. Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients. Acta Oncol. 2014;53(3):399–404.
- Su TS, Liang P, Lu HZ, Liang J, Gao YC, Zhou Y, et al. Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients. J Surg Oncol. 2016;113(2):181–
- Ntandja Wandji LC, Gnemmi V, Mathurin P, Louvet A. Combined alcoholic and non-alcoholic steatohepatitis. JHEP Rep. 2020;23:100101.
- Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67(4):829–
- Younossi Z, Henry L. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality. Gastroenterology. 2016;150(8):1778–85.
How to Cite This Article
Vancouver
Mall A, Kataria T. Etiology of hepatocellular carcinoma- Indian scenario - A changing landscape [Internet]. IP Int J Med Paediatr Oncol. 2025 [cited 2025 Oct 17];11(2):40-45. Available from: https://doi.org/10.18231/j.ijmpo.2025.009
APA
Mall, A., Kataria, T. (2025). Etiology of hepatocellular carcinoma- Indian scenario - A changing landscape. IP Int J Med Paediatr Oncol, 11(2), 40-45. https://doi.org/10.18231/j.ijmpo.2025.009
MLA
Mall, Aprajita, Kataria, Tejinder. "Etiology of hepatocellular carcinoma- Indian scenario - A changing landscape." IP Int J Med Paediatr Oncol, vol. 11, no. 2, 2025, pp. 40-45. https://doi.org/10.18231/j.ijmpo.2025.009
Chicago
Mall, A., Kataria, T.. "Etiology of hepatocellular carcinoma- Indian scenario - A changing landscape." IP Int J Med Paediatr Oncol 11, no. 2 (2025): 40-45. https://doi.org/10.18231/j.ijmpo.2025.009